Advocates: US FDA Pivot To Preventing Rare Disease Symptoms Means Industry Must Adapt

 
• By Sarah Karlin-Smith
  
two tiny newborn babies
The FDA is becoming more comfortable enrolling young children with rare diseases in trials. (Shutterstock)

More from Rare Diseases

More from US FDA